The Indian government started the vaccination drive with Covishield and Covaxin in January this year. However, later it approved Russia's Sputnik-V vaccine for only emergency use. Now, after all these vaccines, people are confused regarding which vaccine is better and more effective than the others. Dr V K Paul, NITI Aayog Health Member and Dr Randeep Guleria AIIMS Director
Covaxin effective against India,UK COVID strains: Bharat Biotech
The study found a modest reduction in neutralisation by a factor of 1.95 against B.1.617 variant compared to vaccine variant D614G, Bharat Biotech noted.
By PTI| Posted by Sakina Fatima | Published: 17th May 2021 1:35 pm IST
New Delhi: Bharat Biotech on Sunday said its COVID-19 vaccine ‘Covaxin’ has been found to be effective against COVID-19 virus strains found in India and the UK.
Citing a study published in peer-reviewed medical journal Clinical Infectious Diseases, the Hyderabad-based vaccine major noted that vaccination with Covaxin produced neutralising titres against all key emerging variants tested, including B.1.617 and B.1.1.7, first identified in India and the UK, respectively.
Covaxin may provide immunity against Covid-19 for about 9 to 12 months and there has been no death reported so far due to Covaxin, nor has there been any case of major side-effects.